Back to BMYView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
3 competitors in Bladder Cancer
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
IpilimumabPhase 3
Prostatic Neoplasms, Castration-Resistant
BMS-986393Phase 3
Relapsed or Refractory Multiple Myeloma (RRMM)
NivolumabPhase 3
Recurrent Head and Neck Squamous Cell Carcinoma
MilvexianPhase 3
Ischemic Stroke; Ischemic Attack, Transient
Nivolumab and rHuPH20Phase 3
Clear Cell Renal Cell Carcinoma
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts